BioNTech SE 20-F for FY2021
BioNTech SE (BNTX)
20-F
2022-03-30
For: 2021-12-31
View Original
Added on
April 07, 2026
About this 20-F
BioNTech SE filed this 20-F on March 30, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 18.98B EUR
- up 3834.6% from 482.3M EUR a year earlier
- Net income
- 10.29B EUR
- up 67613.8% from net income of 15.2M EUR a year earlier
- Diluted EPS
- 39.63 EUR
- up 65950.0% from 0.06 EUR a year earlier